|Day Low/High||81.25 / 83.63|
|52 Wk Low/High||68.25 / 131.94|
Stocks are moving higher as the Fed said it will keep buying bonds. Rite Aid is up and Pier One is down, Take Two is a steal.
BioMarin's R&D update next Tuesday will be the biggest thing in biotech in the coming week, says Adam Feuerstein, Sr. Columnist at TheStreet.
Jim Cramer looks at stocks moving on cancer-fighting develompents, in a discussion with Mad Money Research Director Nicole Urken
Jim Cramer discusses hyper growth names with safety in discussion with Mad Money Research Director Nicole Urken
Adam Feuerstein, Sr. Columnist for TheStreet, says the BIO CEO Conference is the next big thing in biotech.
Adam Feuerstein, senior columnist for TheStreet, says the coming week's J.P. Morgan Healthcare Conference is the next big thing in biotech.
Adam Feuerstein, Sr. Columnist for TheStreet, says Ligand, BioMarin and Sangamo are the next big things to watch in biotech.
Despite the solid performance so far this year, there's still time to get on board and ride the profit train.